Your session is about to expire
← Back to Search
Excimer Laser Trabeculostomy for Glaucoma (ELTGTS Trial)
ELTGTS Trial Summary
This trial will test a new procedure to lower eye pressure in people with early to moderate stage primary open-angle glaucoma who are also having cataract surgery.
ELTGTS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowELTGTS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ELTGTS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with a condition that is causing my vision to worsen over time.My eye pressure is 24 mmHg or less with medication.I am at least 45 years old.I have a specific type of glaucoma not caused by another eye condition.I have a cataract that can be operated on, and my vision is 20/40 or worse.I have been diagnosed with mild to moderate open-angle glaucoma.I have had surgery for glaucoma, eye, or cornea before.I cannot stop taking my current eye medication for the study.
- Group 1: ELIOS Procedure
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the clinical trial being administered in multiple locations throughout the US?
"This trial is administered in 20 different sites throughout the country, including Rock Island, DeLand and Largo. To reduce travelling demands associated with participating in this study, we advise selecting a clinical site that's nearest to you."
Is the current research project actively seeking participants?
"Affirmative. According to the data available on clinicaltrials.gov, this medical trial first went online on May 10th 2021 and was recently updated in September 27th 2022; it is still recruiting patients - 318 participants are needed between 20 sites."
What is the aggregate amount of participants engaged in this experiment?
"That is accurate. According to records on clinicaltrials.gov, this medical experiment has been actively recruiting since May 10th 2021 and was last modified on September 27 2022. As such, the team needs 318 individuals across 20 different sites for participation in their trial."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger